IRCT2015112725256N1招募中2 期
Effects of Metformin plus Temozolamide on Patients with Glioblastoma Multiform
Kerman Neuroscience Research Center0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit（—）
- 性别
- All
入选标准
- •inclusion: GBM diagnosis confirmed by pathology; age>18; KPS>60; normal kidney function
- •exclusion:; no underlining disease which interfere the course of treatment
- •a life threatening diseases other than GBM; DM; infectious disease
- •; lactation or pregnancy
排除标准
- 未提供
研究者
相似试验
已完成
不适用
Phase 2 clinical trial for the efficacy and safety of low dose Temozolomide plus metformin as combination chemotherapy compared with low dose Temozolomide plus placebo in patient with recurrent or refractory GlioblastomaNeoplasmsKCT0002632The Catholic University of Korea, Seoul St. Mary's Hospital81
已完成
2 期
Study on Low Dose Temozolomide Plus Metformin or Placebo in Patient With Recurrent or Refractory GlioblastomaGlioblastomaNCT03243851Yong-Kil Hong81
尚未招募
不适用
Role of metformin in COVID-19 patients with diabetes.CTRI/2022/02/040064Manipal Academy Of Higher Education
招募中
3 期
A comparative study of the use of metformin and ezetimibe compared to the use of metformin in the treatment of non-alcoholic fatty liver disease?Diabetes.Type 2 diabetes mellitus with other specified complicationsE11.6IRCT20090305001745N3Islamic Azad University of Shahrood80
暂停
1 期
A Randomised Double-Blind Controlled Trial of Metformin and Atorvastatin – with treatment commenced following prostatic biopsy and ceasing just before radical prostatectomy - to guide subsequent patient managementCancer - ProstateProstate cancerACTRN12615000571572niversity of Queensland Centre for Clinical Research80